Intraoperative use of stents for the management of unacceptable distal internal carotid artery end points during carotid endarterectomy: Short-term and midterm results  by Ross, Charles B. & Ranval, Timothy J.
420
Intraoperative use of stents for the
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Purpose: The management of unacceptable distal internal carotid artery (ICA) end points
during carotid endarterectomy presents multiple dilemmas. The problem may be expe-
ditiously solved by placement of an intraluminal stent, but reported clinical experience
with this technique is limited. We retrospectively reviewed our experience with intraop-
erative stenting of the ICA for the correction of unacceptable distal ICA end points dur-
ing carotid endarterectomy. We report our techniques and document the 30-day stroke
morbidity-death rate and midterm outcomes of patients treated in this manner.
Method: The records of 316 consecutive carotid endarterectomies performed by the
authors from January 1997 through June 1999 were reviewed to identify those cases in
which adjunctive intraoperative stenting of the distal ICA was used. For those patients
treated with adjunctive ICA stents, we assessed technique, 30-day outcomes, and
midterm outcomes.
Results: The 30-day combined stroke and death rate for the entire group of 316 carotid
endarterectomies was 1.9%. Adjunctive distal ICA stents were used in 13 cases—4.1% of
the total carotid endarterectomy group—for the correction of unacceptable distal ICA
end points. All patients were male; the average age was 70 years. Stents were used in 11
patients because in each of these cases the surgeon recognized an unacceptable end point
and desired to limit further distal anatomic exposures and/or ischemia times. Stents
were used in two patients to correct unexpected defects identified on intraoperative com-
pletion ultrasound scan. No 30-day periprocedural deaths, strokes, or transient ischemic
attacks were observed. Average postoperative length of stay was 1.8 days (range, 1-5
days). All patients have been followed up with serial carotid duplex scans, and one
patient has been studied by means of angiography. No patients have died, and all remain
in active clinical follow-up. Mean length of follow-up has been 15 months. No signifi-
cant asymptomatic recurrences have been observed, but one patient experienced an iso-
lated episode of amaurosis fugax without demonstrable restenosis at 8 months postop-
eratively.
Conclusion: Our experience suggests that the adjunctive use of stents for the correction of
unacceptable distal ICA end points during carotid endarterectomy is safe and provides
acceptable short-term and midterm outcomes. Continued follow-up will be required
before this technique can be considered a primary choice rather than an expeditious sec-
ondary alternative in this infrequent clinical circumstance. (J Vasc Surg 2000;32:420-8.)
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To achieve complete removal of atherosclerotic
disease while avoiding unacceptable distal end points
in the internal carotid artery (ICA) during endarterec-
tomy, experienced carotid surgeons rely on a number
of technical principles. These principles include ade-
quate anatomic exposure of the ICA beyond the distal
extent of plaque, meticulous “feathering” of the distal
end point, use of a patch if the arteriotomy extends
beyond the carotid bulb, extension of patch closure 5
to 10 mm beyond the distal end point, and judicious
use of tacking sutures.1,2 Nevertheless, situations are
occasionally (though rarely) encountered in which sat-
isfactory end points are most difficult to achieve.
When such operative problems are encountered in
patients in whom the ICA arteriotomy has been
extended to or beyond Blaisdell’s line—an imaginary
line between the mastoid process and the angle of the
mandible—the necessity for greater exposure often
means that more time is needed for dissection or still
other maneuvers at a point of considerable inconve-
nience during the operation. Whereas no reports com-
paring the morbidity rates of planned and unplanned
distal ICA exposures are available, the risk of injury to
one or more cranial nerves and the risk for cerebral
ischemia resulting from increased clamp time or
increased shunt manipulation are readily appreciated.
Intraoperative stent placement, accomplished
through use of endovascular techniques or placement
of a self-expanding stent under direct vision, repre-
sents an expeditious method by which to achieve 
normalization of the luminal diameter of the distal
ICA and secure an otherwise unacceptable distal
endarterectomy end point during carotid endarterec-
tomy (CE). Reported experience with this technique
has been limited.3 We have reviewed our experience
with the intraoperative use of stents for the manage-
ment of unacceptable distal ICA end points during
CE to document 30-day periprocedural and midterm
outcomes. Technical details of the procedures are also
described.
METHODS
Patients and indications for treatment.
Between January 1, 1997, and June 30, 1999, 316
CEs (306 primary and 10 reoperative procedures)
were performed on 286 patients with mean age of
70 years; 58% of the patients (n = 166) were male,
and 42% (n = 120) were female. CE was performed
for asymptomatic lesions in 55% of the cases (n =
175) and symptomatic lesions in 45% (n = 141). The
30-day periprocedural combined stroke-death rate
observed was 1.9%. Three cranial nerve injuries were
observed in which deficits were severe enough to
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lengthen hospital stay; one of these involved the
hypoglossal nerve and the other two involved
injuries to both the hypoglossal and glossopharyn-
geal nerves, with one patient requiring a temporary
percutaneous gastrostomy tube.
This report focuses on 13 patients, representing
4.1% of the total CE group, who underwent intra-
operative placement of intraluminal stents for cor-
rection of unacceptable distal ICA end points. All
patients were male; their ages ranged from 57 to 81
years. Presenting symptoms included ipsilateral tran-
sient ischemic attacks in 3 patients, ipsilateral
episodes of amaurosis fugax in 3 patients, ipsilateral
stroke in 1 patient, and syncope in 1 patient. Five
patients were asymptomatic. Eleven patients had pri-
mary lesions. One patient who had had previous rad-
ical neck dissection and irradiation had a sympto-
matic (amaurosis fugax) recurrent lesion more than
10 years after his primary CE. One patient had an
asymptomatic, high-grade recurrent ICA stenosis 6
years after CE with primary closure.
CE technique and identification of unaccept-
able distal ICA end points. General anesthesia was
used in 12 cases and regional anesthesia by cervical
block in one case. All patients received intraoperative
infusion of low molecular weight dextran and sys-
temic anticoagulation with heparin. Shunts were
used selectively in two of the 13 patients. CE with
prosthetic patch angioplasty was used in 11 patients,
whereas two underwent eversion endarterectomies.
Unacceptable distal ICA end points intraopera-
tively became manifest in two ways: (1) as a result of
the surgeon’s concern about visible residual disease or
intimal elements that were considered unacceptable
(11 cases) and (2) from the unexpected finding of a
flap or flow disturbance at the time of completion
intraoperative duplex ultrasound scan (two cases).
In 11 patients, end point defects consisting of 
intimal-medial flaps and/or residual plaque with a par-
tially tethered flap were visualized during the course of
open endarterectomy. In nine of these, the dissection
had proceeded above Blaisdell’s line. The occipital
artery and vein had been ligated and divided and the
hypoglossal nerve fully mobilized with the descending
branch divided. Either the posterior belly of the digas-
tric muscle had been divided, or the muscle had been
mobilized and elevated to a point at which it was not
hindering further immediate distal exposure. The pri-
mary anatomic point at which we decided to halt
extension of the ICA arteriotomy was the point at
which access to the ICA was limited by the vagus and
hypoglossal nerves traveling together in tight proxim-
ity to one another and the ICA. When this point was
reached, great care was taken to ensure that all unat-
tached elements had been removed. The arteriotomy
was then closed with a prosthetic patch or, in the case
of an eversion endarterectomy, closed by completing
the common carotid artery (CCA) anastomosis. When
arteriography was performed, the plan was to correct
the end point with placement of a stent. In two of 11
cases, the surgeon opted to place a stent before closing
the arteriotomy, as discussed in the technique section
that follows.
In two patients, completion duplex ultrasound
scan revealed unexpected end point defects that the
surgeon opted to manage with stent placement. In
each of these cases, the distal dissection had pro-
gressed to Blaisdell’s line, occipital vessels had been
ligated and divided, and the hypoglossal nerve had
been extensively mobilized. Instead of reopening,
the surgeon opted for an endovascular approach.
Stenting techniques for end point correction.
In two of 11 cases, the surgeon opted to place a self-
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Fig 1. A, Distal ICA end point defect noted at completion of CE in 59-year-old man. B, Completion
arteriogram after implantation of 7 × 20-mm Wallstent. C, Selective carotid arteriogram obtained 29
months postoperatively. Note minimal narrowing of lumen within stent caused by intimal hyperplasia.
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expanding stent during the open procedure because
of intimal defects that could not be secured without
unacceptable iatrogenic narrowing of the ICA or
without driving the arteriotomy and endarterectomy
even further distally. Use of an inlying balloon occlu-
sion catheter allowed control of back-bleeding.
Single self-expanding stents were placed under
direct vision, the surgeon ensuring that the midpo-
sition of the stent covered the defect; this allowed
the stent to extend distally beyond the defect and
proximally across the transition point of the
endarterectomy. Patch anastomosis was carried
approximately 5 to 8 mm onto the stented ICA.
Struts of the stent were tacked in the line of anasto-
mosis with simple 6-0 monofilament sutures.
Completion duplex ultrasound scan showed excel-
lent apposition of stent to arterial wall and normal
flow across the stented arterial segment. 
Conversion to an endovascular approach was
used in 11 cases. These operations were performed
in fully equipped endovascular suites with rapidly
available fluoroscopy and endovascular instrumenta-
tion and with in-room capability for the determina-
tion of activated clotting times. Additional heparin
was given to maintain activated clotting times
between 200 and 300 seconds. The CCA or the
patch over the CCA was entered with an 18-gauge
needle-catheter through which a guidewire was
advanced into the carotid bulb or external carotid
artery. The entry catheter was exchanged for a 15-
cm 7F sheath, which was secured to the skin.
Passage of the dilator-sheath through the skin and
platysma before vascular access was used to secure a
flatter angle of entry to the vessel when necessary.
Angiography with dilute, nonionic contrast was then
performed. Defects were identified, and the end
point of the endarterectomy was noted. A guidewire
was then advanced across the end point, allowing
intervention to proceed.
Single self-expanding stents without balloon
angioplasty were used in eight patients, only two of
whom required adjunctive balloon angioplasty.
Multiple self-expanding stents were used in three
patients, one of whom required adjunctive balloon
angioplasty. Self-expanding stents were generally
sized 1 to 2 mm larger than the diameter of the ICA
as estimated by the surgeon. Symphony stents
(Boston Scientific, Natick, Mass) with diameters
ranging from 6.0 to 8.0 mm were used in nine
patients. Wallstents (Boston Scientific) were used in
two patients; one of these stents measured 6 × 20
mm and the other 8 × 20 mm. Short (10-mm long)
balloon-expandable Palmaz stents (Johnson &
Johnson, Princeton, NJ) were placed for control of
end point defects in two patients; these stents had
final diameters of 5.0 mm and 8.0 mm. Examples of
distal end point lesions and their correction by stent
implantation are shown in Figs 1 and 2.
Antiplatelet and anticoagulation therapy. All
patients were initially managed with aspirin, and
they have continued to take it. Three patients, all
receiving warfarin before treatment, have continued
taking warfarin combined with aspirin postopera-
tively. One patient with disease in multiple vascular
beds has been managed with long-term combination
aspirin and ticlopidine. Six patients received combi-
nation aspirin and clopidogrel for 6 weeks and then
long-term aspirin alone. Three patients have been
managed with aspirin alone.
RESULTS
Thirty-day periprocedural outcomes. None of
the 13 patients experienced immediate or 30-day
strokes, transient ischemic attacks, or significant cra-
nial nerve deficits. The postoperative length of stay
was 1 day in 6 patients, 2 days in 6 patients, and 5
days in 1 patient; this last patient required resump-
tion of chronic anticoagulation with warfarin and
stabilization of multiple medical problems, including
hypertension and renal insufficiency, before dis-
charge.
Follow-up and midterm outcomes. The mean
length of postoperative follow-up for this group of
patients was 15 months; five patients were followed
up for 18 months or more. All patients have been
followed up clinically and by means of serial duplex
ultrasound scan. No recurrences of 50% or greater
(identified by ICA peak systolic velocities > 130
cm/s) have been identified. One patient, the index
patient for this group, was studied by means of selec-
tive carotid angiography at the time of cardiac
catheterization both at 6 months and at 29 months
postoperatively and has shown no signs of significant
recurrence and only minimal intimal thickening. The
angiogram obtained 29 months postoperatively is
shown in Fig 1, C.
The patient who was treated for a recurrent
symptomatic carotid stenosis in an irradiated field
and managed with aspirin and warfarin postopera-
tively experienced a single episode of amaurosis
fugax during hospitalization for angina at 8 months
after his operation. He had no recurrence (as deter-
mined by means of duplex scanning) and was not
studied angiographically because of renal insufficien-
cy. He has experienced no further symptoms and has
been actively followed up for 25 months. New or
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recurrent symptoms have not been experienced by
any of the other patients. All patients are alive and
remain in active clinical follow-up.
DISCUSSION
Intraoperative placement of intraluminal stents
for the management of unsatisfactory distal ICA
endarterectomy end points represents an expeditious
technique that addresses a problem eventually expe-
rienced by almost all carotid surgeons. In the usual
circumstance, the distal extent of plaque within the
ICA can be predicted and extensive distal exposure,
if deemed necessary, planned. Even when preopera-
tive arteriograms fail to suggest distal extension of
thick plaque, the problem may be recognized visual-
ly and by palpation on exposure of the ICA, and the
surgeon may extend the dissection before giving
heparin and clamping. However, cases are some-
times encountered in which a perfectly complete
endarterectomy cannot be achieved without extend-
ing the ICA arteriotomy and anatomic exposure
more distally than initially planned. Our experience
suggests that when this problem is encountered in
patients who have high bifurcations and/or exten-
sive disease requiring dissection above Blaisdell’s
line, stents may be safely used to secure the distal
end point.
Encountering any degree of technical difficulty
with an endarterectomy end point is a situation best
avoided. When such problems arise with end points
above Blaisdell’s line, they may be especially trou-
blesome. We were unable to identify exactly how
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Fig 2. A, Distal ICA defect noted at completion of redo-CE in 64-year-old man. B, Correction of
defect with implantation of Palmaz stent. C, Completion arteriogram shows correction of defect. 
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many times we worked at or beyond this level with-
out resorting to the use of a stent during this period
of study, but it is a problem that we are now begin-
ning to prospectively evaluate. Dossa et al4 reported
the use of temporary mandibular subluxation in 14
of 281 patients requiring carotid reconstructions,
eight of which were for CE. Discounting their six
nonendarterectomy cases and assuming that the
remaining 275 cases were endarterectomies, they
reported the use of temporary mandibular subluxa-
tion in approximately 3.0% of CEs during a 33-
month period of study. The frequency of use of dis-
tal ICA stents—4.1% of cases—in the current report
may have been increased because of ease and early
gratifying results. Acceptable rates for the use of
adjunctive distal techniques, whether open or
endovascular, have yet to be established.
Use of intraluminal stents within the ICA
remains investigational (ie, not approved by the US
Food and Drug Administration); however, our strat-
egy of stopping the endarterectomy, ensuring
removal of all grossly loose elements, and correcting
the end point with a stent has a number of advan-
tages. Cranial nerve injuries may be prevented.
Acute perioperative stroke caused by ICA thrombo-
sis or embolization from a bad end point may be
avoided through preservation of normal ICA flow. If
a shunt has been required, expeditious conversion to
an endovascular approach may reduce ischemia time
and avoid excessive shunt manipulation.
Clinically detectable cranial nerve injuries have
been reported to occur in approximately 15% of un-
selected CEs.5-7 Usually, these are self-limited. The
risk and severity of potential cranial nerve injury may
increase with more distal exposures. The glossopha-
ryngeal nerve and the vagus-hypoglossal complex
present substantial hazards. Traction injuries to the
glossopharyngeal nerve may occur even when it is
manipulated gently. The ensuing pharyngeal dys-
function can be morbid and discouraging to patients,
feeding gastrostomy and/or tracheostomy tubes
being required in some.8,9 Injury to the hypoglossal
nerve and vagus nerve may be more easily tolerated
by patients; however, management of these nerves is
especially complex at a point, usually above Blaisdell’s
line, where the vagus supplies fibers to the hypoglos-
sal and a variable length of connective tissue encom-
passes the two nerves.10 The ICA lies deep in the
crotch of the two nerves at this point, and this makes
them particularly susceptible to injury. Other cranial
nerves at risk with extensive distal exposures include
the facial nerve, superior laryngeal nerve, spinal
accessory nerve, and cervical sympathetic chain.
Because intraluminal stents were used in our series of
patients, further exposure of the ICA and traction on
surrounding structures were discontinued at a point
at which the cranial nerves became increasingly 
vulnerable to serious injury. Although it has been
suggested that ICA end point defects detected by
routine completion ultrasound scan during CE may
be corrected by additional exposure and reopening of
the ICA without a statistically significant increase in
cranial nerve injuries,11 our strategy essentially elimi-
nates such risk. 
An intraoperative decision to place a stent under
direct vision or convert to an endovascular approach is
presented in this report as a strategic alternative to
more distal dissection when the need for such exten-
sive exposure has not been recognized preoperatively.
We have performed a number of distal exposures as
planned procedures involving a stepwise approach that
includes ligation and division of the occipital vessels
and descending branch of the hypoglossal, transection
of the posterior belly of the digastric muscle, division
of the styloid process, and use of inlying balloon
catheters for distal control. In all such cases, we have
insisted on irrigating, bipolar cautery and used this as
sparingly as possible. We have found interposition
grafts with spatulated anastomoses helpful because a
thick tongue of plaque may be secured by the posteri-
or suture line and because generous extension of the
anastomotic hood obviates stenosis. We have been able
to satisfactorily complete distal ICA reconstructions
without resorting to vertical ramus mandibulotomy or
anterior subluxation of the mandible. At this time, we
do not have adequate follow-up or experience to sug-
gest the use of planned endovascular conversion and
intraluminal stenting as an alternative to maneuvers
such as mandibular subluxation for the treatment of
atherosclerotic lesions at or near the skull base.
However, strictly with respect to prevention of cranial
nerve injury and efficiency, this technique favorably
compares with traditional surgical approaches.
Correction of unacceptable distal ICA end points
during endarterectomy by stent implantation is
expeditious but significantly adds to the cost of the
procedure. However, time in an operating suite is
also expensive. The total cost for the operative time
required to secure more distal exposure, the time
required to reopen or further secure an end point,
and the time required to assess the result of such
efforts theoretically could exceed the cost of a stent.
Furthermore, the cost of these maneuvers, if they
are complicated by cranial nerve injuries requiring
increased use of hospital resources, could far exceed
the cost of stenting.
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Intraluminal manipulation of freshly endarterec-
tomized ICAs with end point imperfections has
many potential dangers. We do not recommend the
technique to those without advanced endovascular
experience and well-stocked inventories of endovas-
cular instruments. A number of technical misadven-
tures are conceivable, including embolization,
subintimal dissection, and distal ICA or branch per-
forations leading to intracerebral or cavernous hem-
orrhage. We give additional heparin and maintain
activated clotting times between 200 and 300 sec-
onds during these maneuvers to minimize the possi-
bility that thrombus will develop on guidewires,
catheters, or sheaths. We carefully secure the intro-
ducer sheath and vigilantly observe the distal tips of
the guidewires to prevent distal malposition. The
importance of guidewire management and control
cannot be overemphasized, and such control must
be vigorously protected by the surgeon and first
assistant. We cross the distal end point under magni-
fied fluoroscopic guidance. A variety of catheters and
guidewires are kept readily available for facilitating
these maneuvers. In addition, CEs are performed in
operating endovascular suites equipped with radio-
lucent tables that allow for immediate fluoroscopy
without any need to reposition the patient. We have
thus been able to proceed intraoperatively from
standard open CE to adjunctive endovascular tech-
niques with minimal effort.
Melissano et al3 reported two cases in which Easy
Wallstents (Boston Scientific) were used to correct
severe end point defects after eversion endarterec-
tomies. In one of these cases, the defect was discov-
ered intraoperatively before closure and stented. In
the other case, a patient experienced a transient
ischemic attack 1 hour after CE; angiography subse-
quently revealed a flap at the distal ICA end point,
which was corrected by placement of an Easy
Wallstent through use of a transfemoral approach.
Acute closure was prevented in these cases. No 
follow-up information was provided. By the time the
report of Melissano et al3 appeared, we had accu-
mulated sufficient immediate and midterm follow-
up experience with the technique to consider it a
useful alternative to unplanned exposures of the ICA
beyond Blaisdell’s line. Close follow-up of our series
of patients continues.
The use of a stent to correct an unacceptable dis-
tal ICA end point differs greatly from the primary
use of balloon angioplasty with stent implantation
for treatment of atherosclerotic disease of the carotid
bifurcation or more distal cervical ICA. When we
use the technique, the atheroma and all unattached
elements have been removed. The threat of
embolization, therefore, comes not from primary
disease but from the potential development of
thrombus on the freshly endarterectomized surface
or on sheaths and guidewires. This threat is pre-
ventable through adherence to sound surgical and
endovascular technique, including adequate sys-
temic anticoagulation, wiping of wires, and careful
flushing of the sheath. 
Further differences between balloon and stent
angioplasty for primary bifurcation disease and use
in distal end point management relate to the posi-
tion of the stent in the distal ICA and to the role of
balloon angioplasty. The distal cervical ICA is a rel-
atively straight artery, provided that there are no
kinks, coils, or segments with marked redundancy.
Stents placed in this position may be less exposed to
stresses of flexion and extension of the neck than are
those placed across the bifurcation, as now advocat-
ed by proponents of balloon angioplasty and stent-
ing for carotid disease. The role of balloon angio-
plasty also differs. When used for primary treatment
of stenotic atheromas, balloon inflation must neces-
sarily traumatize the artery to accomplish separation
of the plaque and adjoining intima and media.
However, balloon angioplasty in the situations
described in this report was necessary in less than
one half of the cases, and when it was used, its pur-
pose primarily was to ensure proper complete expan-
sion and apposition of stents and arterial wall. 
The risk of recurrent stenotic disease in the distal
ICA because of intimal hyperplasia developing either
within or at the margins of an indwelling stent is
unknown. Liu et al12 recently reported experience
with seven patients in whom stents were used for the
management of dissections of the cervical portion of
the ICA. Follow-up averaging 20 months with either
conventional or computed tomographic angiography
showed no evidence of restenosis in six patients. In
their seventh patient, the same group used a covered
stent (Gore-Tex, Flagstaff, Ariz) that went on to
asymptomatic occlusion 3 months after implantation.
Bernstein et al13 reported implantation of a 5.0 × 20-
mm Wallstent for treatment of a dissection involving
the cervical-petrous portion of the ICA with minimal
intimal hyperplastic narrowing at 12 weeks (as
assessed angiographically) and stable clinical out-
come at 13 months. We believe that the use of stents
to treat dissections in the distal ICA may be more
analogous to our manner of using stents in this series
than would be a comparison to balloon-stent angio-
plasty for primary bifurcation disease.
Although intimal hyperplasia remains a valid
JOURNAL OF VASCULAR SURGERY
426 Ross and Ranval September 2000
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 3 Ross and Ranval 427
concern, a number of recent reports have advocated
balloon angioplasty with stent implantation as an
alternative to reoperative therapy for recurrent ICA
stenoses of hemodynamic significance after
endarterectomy, a process in which intimal hyperpla-
sia plays a primary pathogenetic role.14,15 In 16 such
patients treated with balloon angioplasty and stent-
ing, Hobson et al14 reported no recurrent stenoses
greater than 50% in severity; the average follow-up
was 11 months. Lanzino et al15 reported recurrence
greater than 50% in one of 18 patients with variable
follow-up in which post-CE recurrences were treat-
ed with transcatheter balloon angioplasty and stent-
ing. Clearly, longer follow-up and experience with
more patients will be required to define the real risk
of restenosis in this setting.
The need to address unacceptable endarterecto-
my end points in the distal ICA remains problemat-
ic. Intraoperative stent implantation for end point
correction is presented as an alternative to more dis-
tal dissection. We have been able to do this safely
and have achieved acceptable early and midterm
results. Continued follow-up will be required before
the technique can be considered a primary choice
rather than an expeditious secondary alternative in
this infrequent clinical circumstance.
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DISCUSSION
Dr G. Patrick Clagett (Dallas, Texas). . . . up to the
base of the skull and the lesion is still going, and this is a
potential bailout. Dr Eidt you have been uncharacteristi-
cally silent. What do you think of this? 
Dr John Eidt (Little, Rock, Ark). About 6 weeks ago
we had just read the abstracts for the program committee,
and I went back to Little Rock. Dr Moursi called me over
to his room and said they had a patient that had a radiat-
ed carotid, recurrent symptomatic stenosis, and he could
not get a smooth end point. At the end of the case, it had
a pulse and it looked okay, but there was just no flow on
arteriogram. We placed a stent over the flap at the base of
the skull, and it looked pretty good. One of the things that
worried us was how stenting works when you are inside a
bony canal. Which kind of stent is best in that condition?
Is a Wallstent the right stent because it conforms, or is a
Palmaz stent the better way to go? Or others?
Dr Charles B. Ross. Our experience suggests that self-
expanding stents are the best stents to use in the distal cer-
vical portion of the internal carotid artery. We have not
attempted balloon angioplasty with stent implantation for
lesions at the level of the petrous portion of the internal
carotid artery. The petrous portion of the internal carotid
artery may be especially prone to dissection, so we view
any intervention or even guidewire traversal of a diseased
petrous internal carotid artery segment with great caution.
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However, there are those in the audience who have treat-
ed intracranial internal carotid artery lesions with stent-
angioplasty, yet I have no personal experience with such
lesions.
Dr Thomas C. Naslund (Nashville, Tenn). In terms of
the intrapetrous portion, a balloon-expanded coronary
stent works pretty nice. I have done that with a Wiktor
stent with success.
Dr Clagett. Dr Kwolek.
Dr Christopher J. Kwolek (Lexington, Ky). I want to
congratulate Dr Ross on a very nice presentation, demon-
strating an intervention that is going to allow us to expand
our capability to get out of a difficult situation. I have sev-
eral comments and questions for Dr Ross. 
When you are in the operating room with these situa-
tions, this is not a standard C-arm imaging system we are
talking about, and I think that it is important for the audi-
ence to realize this. We are talking about having digital
subtraction capability and road mapping capability, so that
we are allowed to completely visualize the petrous portion
and the intracranial portions of the carotid artery. Can you
comment about the need to be very cognizant about
where the distal tip of that wire is going? We can create
many more problems intracranially if we are not aware of
the exact position of the wire tip. 
Secondly, were you using the balloon-expandable
stents early in your series and then changed to the self-
expanding stents because of concerns about extrinsic 
compression? There have been a few case reports in the 
literature discussing extracranial carotid stenting and
angioplasty with Palmaz balloon-expandable stents with
subsequent compression. 
With respect to the self-expanding stents, we have
found that the nitinol-based Symphony stents tend to be
very rigid and do not follow the tortuosity of vessels as
well as a Wallstent or Smart stent.
Finally, what are you using for antiplatelet agents after
your angioplasty and stenting? We are using either Ticlid
or Plavix as an antiplatelet agent, based mostly on the
coronary literature, to give us some protection against
increased thrombotic events.
Dr Ross. Thank you, Chris. We try to do all of our
carotid endarterectomies in fully functional endovascular
operating suites. At one of our hospitals, we have a com-
plete ISS room with fixed C-arm, always ready to go. We
also have the OEC-9800 C-arm with a 12-in image intensi-
fier at that hospital and use this C-arm for more complex
cases. At our other hospital, our endovascular suite is
equipped with the ISS carbon fiber table, and we use a
portable Ziehm C-arm, which has a 12-in image intensifier
with DSA capabilities, specifically dedicated to that room.
We keep all of our endovascular equipment on carts, readi-
ly available. We do in-room determinations of activated
clotting times. Hence, we are always ready to obtain
angiograms and to convert to endovascular procedures dur-
ing standard operative cases with minimal waste of time.
Your comments about guidewire control cannot be
overemphasized. One needs a soft-tipped guidewire. We
have used the soft-tipped 0.035 Bentson wire without any
problems. We have also used 0.018 wires with soft tips.
On one occasion in which I thought guidewire traversal
would be especially difficult, I employed a #4-F angle-
tipped Glide catheter and angle-tipped glide wire to nego-
tiate across the end point. Once across, I obtained an arte-
riogram to confirm safe passage without dissection, then
went forward with stent implantation.
Extrinsic compression has been reported with the use
of balloon-expandable stents at levels below the distal cer-
vical portion of the internal carotid artery. Such cases have
included stents used to correct proximal end points with-
in the common carotid artery and stents used to primarily
treat lesions of the carotid bulb or the proximal internal
carotid artery. In the cases we have reported in the present
experience, stents have been used in the distal cervical
internal carotid artery in fairly straight segments not
involving areas of tortuosity or kinking. I do worry about
the stiffness of the Symphony nitinol stent, but so far, it
has not caused a problem. We have used balloon-expand-
able stents approximately 1 cm in length in the present
series only to treat very focal defects, and these have
worked just fine.
Regarding antiplatelet agents, all patients have
received aspirin. We have added Plavix for a duration of 6
weeks as a routine. One patient, on Ticlid preoperatively,
has remained on Ticlid for long-term therapy. Patients
already on Coumadin have been continued on Coumadin
and aspirin in combination. Two patients complied only
with aspirin therapy and did well; however, as a rule, we
have used combination aspirin and Plavix for 6 weeks, fol-
lowed by long-term aspirin alone.
Dr Clagett. I am going to take the liberty as moderator
to cut the discussion. There is a lot of interest in this and
I suggest that you seek out Dr Ross later. Thank you, Dr
Ross, for your presentation. 
